Complex Litigation Blog - Recent Legal News

View updates for:
Published: September 20th, 2016
Bernstein Liebhard LLP is now actively filing product liability cases involving the alleged link between proton pump inhibitors and serious kidney complications. On August 26th, the Firm filed a Nexium lawsuit in the U.S. District, Eastern District of New York, on behalf of an Illinois man who al...Read More
Published: September 14th, 2016
The federal multidistrict litigation established last year for Zofran birth defects lawsuits continues to grow, with nearly 300 cases now pending in the U.S. District Court, District of Massachusetts. Most recently, a Texas couple submitted a Short-Form Complaint on behalf of two children, includ...Read More
Published: September 6th, 2016
A Philadelphia Common Pleas Court judge has added $6.7 million in delay damages to the $70 million verdict awarded to a Risperdal gynecomastia plaintiff earlier this summer. Meanwhile, the company has lodged an appeal of a $500,000 verdict rendered in an earlier Pennsylvania case, asserting that the...Read More
Published: August 29th, 2016
A new study suggests that children who use Concerta, Ritalin or other ADHD medications containing methylphenidate may be more likely to experience abnormal heart rhythms. While the risk is small, the authors of the report advised doctors to take their findings into account when prescribing the medic...Read More
Published: August 25th, 2016
July 7, 2016 Bernstein Liebhard LLP announced today that the Firm was ranked, for the 10th consecutive year, as one of the top plaintiffs’ firms in the country for securities litigation by The Legal 500, a guide to the “best of the best – the pre-eminent firms in the world’s strongest and...Read More
Published: August 24th, 2016
The U.S. Food & Drug Administration (FDA) has declined to approval a medication intended to reverse internal bleeding associated with Xarelto and other new-generation anticoagulants. According to a recent announcement from Portola Pharmaceuticals, the agency says it needs additional information ...Read More
Published: August 15th, 2016
The manufacturers of Levaquin and Avelox have been named defendants in two new lawsuits by patients who allegedly developed peripheral neuropathy due to their use. Both cases, which were filed earlier this month in the U.S. District Court, Eastern District of Pennsylvania, claim that the pharmaceuti...Read More
Published: August 8th, 2016
The $70 million Risperdal verdict awarded last month to a teenaged gynecomastia plaintiff has survived a first challenge by Johnson & Johnson. According to an Order issued on July 26th, the Court was not swayed by the company’s assertion that improper and irrelevant evidence had been presented...Read More
Published: August 1st, 2016
A new Onglyza lawsuit has been filed in Kentucky that accuses Bristol-Myers Squibb and AstraZeneca of concealing the  cardiovascular side effects potentially associated with the Type 2 diabetes medication. According to a complaint filed last month in the U.S. District Court, Western District of Ken...Read More
Published: July 25th, 2016
The federal litigation overseeing hundreds of Zofran lawsuits convened its most recent Status Conference on July 21st. Among other things, the Court was scheduled to hear oral arguments regarding GlaxoSmithKline’s Motion for Sequenced Discovery. According to documents pending in the U.S. Distri...Read More